Home
>
US Stocks
>
Edgewise Therapeutics Inc
Edgewise Therapeutics Inc
EWTX

Edgewise Therapeutics Inc (EWTX)

$16.820.72%

  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open$16.6
Today Low/High$16.22 / $17.1
52 Week Low/High$13.6 / $40.49
Market Cap$788.19M

Company Details

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Guided by its holistic drug discovery approach to targeting the muscle as an organ, Edgewise has combined its foundational expertise in muscle biology and small molecule engineering to build its proprietary, muscle focused drug discovery platform. Edgewise’s platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases.
OrganisationEdgewise Therapeutics Inc
Employees19

Discover more

Frequently Asked Questions

What is Edgewise Therapeutics Inc (EWTX) share price today?

Can Indians buy Edgewise Therapeutics Inc (EWTX) shares?

How can I buy Edgewise Therapeutics Inc (EWTX) shares from India?

Can Fractional shares of Edgewise Therapeutics Inc (EWTX) be purchased?

What are the documents required to start investing in Edgewise Therapeutics Inc (EWTX) stocks?

We are a SEBI registered investement advisor